Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.
- Eligible Ages
- Over 18 Years
- Eligible Genders
- Accepts Healthy Volunteers
- Perinatal HIV infection as documented in the medical record; - At or beyond their 18th birthday at the time of informed consent with no upper age limit; - Willingness to provide access to existing medical records; and - Willingness to participate and provide legal consent
- Prisoner status
- Study Type
- Observational Model
- Time Perspective
|Infected Cohort||Perinatally HIV-infected participants at or beyond their 18th birthday at enrollment.|
- Harvard School of Public Health (HSPH)
Study ContactLiz Salomon, EdM
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood. The primary objectives of this study are: 1. To identify infectious and non-infectious complications of HIV disease and toxicities resulting from long-term ART, including disease progression, immune suppression, viral resistance, end-organ disease, and mortality. 2. To define the impact of HIV infection and ART on the long-term clinical outcomes of young adults with perinatal HIV. 3. To define the impact of perinatal HIV infection and ART on long-term mental and behavioral health outcomes.